Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Effect of the STK11 mutation on therapeutic efficacy and prognosis in patients with non-small cell lung cancer: a comprehensive study based on meta-analyses and bioinformatics analyses

Fig. 3

Subgroup analysis for HR of progressive disease and death in STK11mut patients with NSCLC. (A) Subgroups were grouped by ethnicity to compare HR of progressive disease. (B) Subgroups were grouped by ethnicity to compare the HR of death. (C) Subgroups were grouped by whether received ICIs to compare HR of progressive disease. (B). Subgroups were grouped by whether received ICIs to compare HR of death

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us